Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Kling Biotherapeutics Appoints Michael Koslowski, M.D. As Chief Executive Officer
Kling Biotherapeutics, a clinical-stage company pioneering the discovery and development of novel antibody-based therapeutics, today […]
HitGen Announces Research Agreement with Nitrase Therapeutics Focused on DNA-Encoded Library Based Drug Discovery
Shanghai Stock Exchange-listed company HitGen has announced that it has entered into a research agreement […]
Graciela Racaro Joins Signant Health as Chief Operating Officer
Signant Health, the leader in evidence generation for modern clinical trials, has announced the appointment […]
Stride Health Appoints Peter V. Lee, Former Executive Director of Covered California, to Board of Directors
Stride Health, the leader in portable benefits technology, announced the appointment of Peter V. Lee […]
CDR-Life Announces the Appointment of Nicole Onetto, MD, MSc, to Board of Directors
CDR-Life, a biotechnology company pioneering a new and differentiated class of highly tumor-selective immuno-oncology therapeutics […]
Ankyra Therapeutics Appoints Leisha A. Emens, M.D., Ph.D., as Senior Vice President, Translational Research
Ankyra Therapeutics, a biotech company developing targeted immune-activating agents for the treatment of cancer, today […]
Medikine Appoints Roland Buelow, Ph.D., to Board of Directors
Medikine, a clinical-stage biopharmaceutical company developing transformative therapeutics for cancer, autoimmune disorders, and infectious diseases […]
Carle Health Partners with Health Catalyst to Achieve Data-Informed Improvement
Health Catalyst, a leading provider of data and analytics technology and services to healthcare organizations, […]
NRx Pharmaceuticals Appoints Carrie M. Carretta as Senior Vice President of Clinical Development and Medical Affairs
NRx Pharmaceuticals, a clinical-stage central nervous system (CNS) biopharmaceutical company, has announced the appointment of […]
Telix Announces Executive Leadership Appointments
Telix Pharmaceuticals has announced several key executive leadership appointments and promotions, reflecting the increased commercial […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more